Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
Philippa has the latest weather for the east
Philippa has the latest weather for the west
Bournemouth pulled off one of the comebacks of the season to beat Liverpool for the first time. They came back from 3-1 down to win 4-3